Yi-ju Ko

Title: Innovations in Cancer Treatment by Yi-ju Ko

Introduction

Yi-ju Ko is an accomplished inventor based in Xinbei, Taiwan. She has made significant contributions to the field of cancer treatment through her innovative research and development of targeted drug delivery systems. Her work focuses on enhancing the efficacy of cancer therapies while minimizing side effects.

Latest Patents

Yi-ju Ko holds a patent for a "Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof." This invention relates to a sophisticated drug delivery system that utilizes liposomes labeled with IL4RPep peptides. These peptides specifically bind to interleukin-4 receptors, which are overexpressed in certain cancer cells. The liposomes can deliver anticancer drugs directly to these targeted cells, improving treatment outcomes and reducing side effects on normal tissues. This innovative approach also facilitates in vivo molecular imaging and early diagnosis of tumors.

Career Highlights

Throughout her career, Yi-ju Ko has worked with notable institutions such as the Kyungpook National University Industry-Academic Cooperation Foundation and the Industrial Technology Research Institute. Her experience in these organizations has allowed her to advance her research and contribute to the development of cutting-edge cancer therapies.

Collaborations

Yi-ju Ko has collaborated with esteemed colleagues, including In San Kim and Byung Heon Lee. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in cancer treatment.

Conclusion

Yi-ju Ko's contributions to cancer treatment through her targeted drug delivery system exemplify the potential of innovative research in improving patient outcomes. Her work not only advances scientific knowledge but also holds promise for future applications in oncology.